EVALUATION OF AN ORAL SUSTAINED RELEASE DOSAGE FORM OF TRIMEPRAZINE AS MEASURED BY URINARY EXCRETION

被引：10

作者：

HEIMLICH, KR

MACDONNELL, DR

POLK, A

FLANAGAN, TL

机构：

来源：

关键词：

D O I：

10.1002/jps.2600500308

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：213 / &

共 15 条

[1] BERTI T, 1956, Farmaco Sci, V11, P451
[2] CAMPBELL J A, 1959, Can Med Assoc J, V81, P15
[3] EIDUSON S, 1958, T 2 RCP, V2, P88
[4] GREENBERG SM, AM J CLINICAL NUTRIT
[5] MACDONNELL DR, 1955, BP 742 007
[6] A NOTE ON MATHEMATICS OF ORAL SUSTAINED RELEASE PRODUCTS
NELSON, E
[J]. JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1957, 46 (09): : 572 - 573
[7] SULFAETHYLTHIADIAZOLE .6. BLOOD AND URINE CONCENTRATIONS FROM SUSTAINED AND IMMEDIATE RELEASE TABLETS
NICHOLSON, AE
TUCKER, SJ
SWINTOSKY, JV
[J]. JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1960, 49 (01): : 40 - 44
[8] PHYSIOLOGICAL AVAILABILITY OF THE VITAMINS - STUDY OF METHODS FOR DETERMINING AVAILABILITY OF VITAMINS IN PHARMACEUTICAL PRODUCTS
OSER, BL
MELNICK, D
HOCHBERG, M
[J]. INDUSTRIAL AND ENGINEERING CHEMISTRY-ANALYTICAL EDITION, 1945, 17 (07): : 405 - 411
[9] SULFAETHYLTHIADIAZOLE .5. DESIGN AND STUDY OF AN ORAL SUSTAINED RELEASE DOSAGE FORM
ROBINSON, MJ
SWINTOSKY, JV
[J]. JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1959, 48 (08): : 473 - 478
[10] SHENOY K G, 1959, Drug Stand, V27, P77